DNMT1

DNMT1
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	DNA (cytosine-5)-methyltransferase 1
Organism	Human
Locus	Chromosome 19
Length	~1616 aa

DNMT1 DNMT1 is a major eukaryotic maintenance DNA methyltransferase involved in copying cytosine methylation patterns after DNA replication. Identified in studies involving Hermann Muller, Barbara McClintock, Oswald Avery, James Watson, and Francis Crick-era genetics, it links chromatin state to cell fate decisions observed in models used by Gregor Mendel, Thomas Hunt Morgan, Sydney Brenner, John Sulston, and Matthew Meselson. DNMT1 function has been examined across systems from Caenorhabditis elegans to Mus musculus and Homo sapiens, with implications explored by groups at institutions such as Cold Spring Harbor Laboratory, Max Planck Society, Harvard University, Massachusetts Institute of Technology, and Broad Institute.

Introduction

DNMT1 was first characterized in biochemical and genetic screens paralleling discoveries by Arthur Kornberg, Severo Ochoa, Marshall Nirenberg, Walter Gilbert, and Fred Sanger in nucleic acid enzymology. Research spanning laboratories at National Institutes of Health, European Molecular Biology Laboratory, University of Cambridge, University of Oxford, and Stanford University established DNMT1 as the predominant maintenance methyltransferase in mammalian somatic cells. Studies leveraging model organisms like Drosophila melanogaster, Saccharomyces cerevisiae, Danio rerio, and Xenopus laevis contributed to mapping its developmental roles, while clinical translational work at Johns Hopkins University and Mayo Clinic linked DNMT1 to human pathologies.

Structure and Isoforms

DNMT1 comprises multiple domains including an N-terminal regulatory region and a C-terminal catalytic domain structurally related to bacterial methyltransferases characterized by pioneers such as Kary Mullis and groups at Salk Institute. High-resolution structures obtained using methods developed at EMBL-EBI and facilities like SLAC National Accelerator Laboratory reveal motifs conserved with enzymes studied by Richard Henderson and Ada Yonath. Isoforms arise from alternative promoter usage and splicing, with cell-type-specific variants described in tissues examined by researchers at UCLA, University of Chicago, Yale University, and University of Pennsylvania. Comparative genomics across taxa handled by consortia including Ensembl, 1000 Genomes Project, and Human Genome Project show conservation in mammals studied by teams at National Human Genome Research Institute.

Enzymatic Mechanism and Substrate Specificity

DNMT1 catalyzes transfer of a methyl group from S-adenosyl methionine to the 5-position of cytosine within CpG dinucleotides, a mechanism elucidated using approaches from labs of Paul Modrich, Azim Surani, and Andrew Fire. Kinetic and mutational analyses influenced by work at Cold Spring Harbor and Cornell University detail base-flipping and active-site nucleophile formation similar to enzymes in studies by Adrian Ferré-D'Amaré. Substrate preference for hemimethylated DNA was characterized alongside discoveries by teams at Imperial College London and Karolinska Institutet, integrating models proposed by John Gurdon and Rudolf Jaenisch about epigenetic inheritance.

Regulation and Interacting Proteins

DNMT1 activity and localization are regulated by post-translational modifications and interactions with proteins including proliferating cell nuclear antigen characterized by Leland H. Hartwell, Paul Nurse, and Tim Hunt; UHRF1 discovered by groups at University of Tokyo and Max Planck Institute; histone-modifying enzymes studied by Bert Vogelstein-associated teams; and chromatin remodelers investigated at University of California, Berkeley and ETH Zurich. Cell cycle cues from pathways elucidated in landmark work by Sydney Brenner and Harald zur Hausen intersect with DNMT1 regulation, and signaling nodes mapped by investigators at Cold Spring Harbor and Dana-Farber Cancer Institute modulate its recruitment to replication foci.

Biological Functions and Developmental Roles

DNMT1 maintains DNA methylation patterns critical for genomic imprinting first described by Mary Lyon and C. H. Waddington, X-chromosome inactivation characterized by Lyon and studied at University of Cambridge, and repression of transposable elements explored by research teams at Salk Institute and Broad Institute. Its role in embryogenesis was demonstrated in knockout studies in Mus musculus led by labs at Jackson Laboratory and Max Planck Institute for Molecular Genetics, linking DNMT1 to lineage specification frameworks promoted by Shinya Yamanaka and James Thomson. Neural development work at Stanford University School of Medicine and hematopoiesis studies at Fred Hutchinson Cancer Center show DNMT1 impacts differentiation and tissue homeostasis.

Clinical Significance and Disease Associations

Mutations, dysregulation, or mislocalization of DNMT1 are implicated in cancers analyzed by investigators at Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Dana-Farber Cancer Institute, in neurodegenerative conditions described by neurologists at Mayo Clinic and Massachusetts General Hospital, and in hereditary syndromes studied at NIH Clinical Center. DNMT1-directed therapies include nucleoside analogues developed following chemistry advances by Gertrude Elion and trials run by consortia including European Medicines Agency and Food and Drug Administration. Epigenetic biomarkers involving DNMT1 activity are under evaluation at Roche, Pfizer, and academic translational programs at University College London.

Experimental Methods and Research Tools

DNMT1 is studied using techniques from structural biology pioneered at Max Planck Institute for Biophysical Chemistry, sequencing platforms born of projects at Illumina and Oxford Nanopore Technologies, and genome editing tools derived from discoveries at UC Berkeley and Broad Institute associated with Jennifer Doudna and Emmanuelle Charpentier. Proteomics pipelines established at ProteomeXchange sites, chromatin assays from Rockefeller University labs, and mouse models maintained at Jackson Laboratory are routinely employed. Chemical inhibitors, antibodies produced by vendors collaborating with Thermo Fisher Scientific, and CRISPR screening protocols developed at Broad Institute enable functional interrogation of DNMT1 in cell lines from repositories such as ATCC.

Category:Proteins